ISTAMET D IR 5/50/500 (Dapagliflozin (5mg) + Metformin (500mg) + Sitagliptin (50mg))

Istamet D-IR 5/50/500 Tablet is a medication formulated to assist in managing blood glucose levels in individuals diagnosed with type 2 diabetes mellitus. This therapeutic agent is intended to be utilized alongside a balanced diet and a structured exercise regimen to effectively enhance blood sugar regulation. The combination of its components works by promoting the efficient use of insulin in the body, which is essential for maintaining optimal glucose levels. Patients are advised to take the tablet consistently at the same time each day, regardless of meal times, to establish a routine. Dosage will be determined by a healthcare professional, and it is critical not to discontinue use without prior consultation, as doing so may result in increased blood sugar levels and raise the risk of serious health issues such as renal impairment and vision loss. This medication is only one aspect of a comprehensive treatment strategy that should also incorporate dietary management, physical activity, and weight loss strategies as recommended by a physician. Staying well-hydrated during treatment is important to prevent dehydration. Patients may also experience a risk of fungal infections in the genital area, which can be mitigated through good hygiene practices. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.